Author | I. Craig Henderson, MD


With Decades of Perspective, Craig Henderson Observes That Treatment of Breast Cancer Has Come a Long Way

May 15, 2017

In this interview we discuss important developments in the diagnosis and management of breast cancer and more.

Bisphosphonates: Game Changers?

January 15, 2015

Bisphosphonates or the monoclonal antibody denosumab, have the potential to profoundly affect the entire metastatic process, not just the growth of bone metastases.

Targeted Therapy: A Sea Change in the Treatment of Cancer

November 16, 2012

I see a time in the not too distant future when we’ll define tumors this way. What will our subspecialties be? Rather than a breast clinic or a lung clinic, will we perhaps be attending a “HER2 clinic” or an “mTOR clinic” instead?

Can We Abandon Anthracyclines for Early Breast Cancer Patients?

February 15, 2011

The anthracyclines doxorubicin and epirubicin are among the most effective cytotoxic treatments developed for the treatment of breast cancer.